A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy

Table 6

Average outcome measures for the different levels of final pain.

Last reported VAS	% study sample (N = 240)	7-day VAS (after 7-day treatment)	Δ VAS (baseline: last reported)	Δ QoL (baseline: last reported)	Δ sleep (baseline: last reported)	Δ medications (baseline: last reported)	Δ physical activity (baseline: last reported)	% stopped medication use	% stopped nondrug pain therapies
0–1	18%	1.43	7.41	+5.48	+2.22	+3.02	+2.18	34	23
2–3	39%	2.71	5.54	+5.07	+1.99	+2.5	+1.86	16.5	17
4–5	28%	3.59	3.91	+4.6	+1.76	+2.02	+1.4	13.5	14
6–7	12%	4.31	2.58	+3.95	+1.23	+0.57	+0.98	0	13
8–10	3%	5.00	−0.33	+3.50	+1.00	+0.50	+0.83	0	0

Numerical values for the change measures can be found in Table 1.